Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry

Haematologica. 2024 Apr 4. doi: 10.3324/haematol.2023.284678. Online ahead of print.ABSTRACTNot available.PMID:38572549 | DOI:10.3324/haematol.2023.284678

Source: Haematologica - April 4, 2024 Category: Hematology Authors: Tommaso Francesco Aiello Jon Salmanton-Garcia Francesco Marchesi Barbora Weinbergerova Andreas Glenthoj Jens Van Praet Francesca Farina Julio Davila-Valls Sonia Martin-Perez Shaimaa El-Ashwah Martin Schonlein Iker Falces-Romero Jorge Labrador Uluhan Sili Source Type: research